pathology
revealed
News & Articles

imageDx: NASH – A New Generation of Quantitative NASH Data
Traditional NAFLD Activity Scoring Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of liver dysfunction, with some estimates suggesting up to 30% of the general population as being affected (1). NAFLD,

Spheroids: Research in 3D
What Are Spheroids? A spheroid is a small, spherical cluster of cells that acts as a 3D cell culture. The term “organoid” is also used interchangeably with “spheroid”, although the former specifically refers to a

Precision Histology: Quantitative Masson’s Trichrome
What is Masson’s Trichrome? Masson’s Trichrome is one of the most common histological stains used to distinguish between muscle and collagen in tissue samples. While the original formulation has changed over the years, Masson’s Trichrome

Image Analysis: Enabling Data Powered Pathology
The rise of whole slide imaging has enabled a variety of computational tools to facilitate the extraction of quantitative data from tissue samples on microscope slides. The practice of using computational algorithms to collect these

AACR Highlights: Focus on AI
The 110th Annual Meeting of the American Association for Cancer Research launched on March 30th, 2019 in Atlanta, GA. Over 22,000 delegates attended including scientists, clinicians, and patient advocates from around the globe. A team

Reveal Biosciences, a Global Pathology AI Leader, Raises Series A Funding Led by Intel Capital
San Diego, CA. (April 2nd, 2019). Reveal Biosciences, Inc., a leader in pathology AI, announces today that it has closed a Series A financing round led by Intel Capital with additional investment from the GNI

Whole Slide Imaging: A Crash Course
The Digital Pathology Association recently released a white paper that provides a comprehensive overview of whole slide imaging, including the challenges and advantages of implementing this technology into existing workflows. You can read the full

Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice
Reveal Biosciences attended Biocom’s recent CRO seminar on Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice. Pharmatest Services and Taconic Biosciences hosted this informative seminar where they presented on humanized immune system models for

Tech Spotlight: Meet the Tech Exec Interview with Dr. Claire Weston
Reveal Biosciences Founder and CEO, Dr. Claire Weston, was recently featured in the Tech Spotlight interview series. This interview covered topics such as the inception of Reveal Biosciences, the future impact of AI on pathology,

Reveal Biosciences Webinar Recap: Revolutionize Pathology Using Artificial Intelligence
Casey Laris, CTO of Reveal Biosciences, lead a webinar entitled “Revolutionize Pathology using Artificial Intelligence” as part of the Science Exchange Webinar Series. Highlights from this webinar include: Reveal Biosciences specializes in data powered pathology.